![Michael N. Avallone](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Michael N.
Avallone has been Chief Financial Officer of AMAG Pharmaceuticals, Inc. since joining the company in July 2004 and Vice President of Finance since August 2004.
From 2000 to 2004, Mr. Avallone worked at Boston Biomedica, Inc., including as Corporate Controller and Vice President of Finance and Chief Financial Officer.
He held various executive positions in accounting and finance at affiliates of NSTAR.
Ehemalige bekannte Positionen von Michael N. Avallone
Unternehmen | Position | Ende |
---|---|---|
AMAG PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 21.03.2007 |
PRESSURE BIOSCIENCES, INC. | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PRESSURE BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
AMAG Pharmaceuticals, Inc.
![]() AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |